CRB’s Horizons: Life Sciences 2025 report finds 50% of large life-science firms accelerating U.S. capital projects and 65% adopting continuous-manufacturing systems as tariffs and FDA restructuring ...

This spring, the Trump administration renewed calls to bring drug manufacturing and production back to American shores, reigniting debate about what it will take to move onshoring from a lofty dream ...

Amid a trade war that could strain imports of lifesaving pharmaceuticals, President Donald Trump wants to ease regulations and bolster domestic drug manufacturing. The president signed an order on May ...

Drug Substance manufacturing is a critical component of pharmaceutical production, requiring precise processes, rigorous quality control, and innovative solutions to overcome various challenges. From ...

Drug formulation is becoming increasingly complex. Poorly soluble APIs, personalized medicines, and advanced oral dosage forms require production methods that are scalable, reproducible, and precise.

Continuous pharmaceutical manufacturing represents a significant shift from traditional batch processing, integrating continuous flow methods, advanced process analytical technology (PAT) and ...

Continuous manufacturing makes monoclonal antibody production faster, cheaper, and greener, say researchers, who predict that industry adoption of the approach will accelerate in response to ...

Basel-based Lonza joined CMAC, a center for medicines manufacturing research, to enhance its service offering for particle technologies and drug product development and manufacture. Based at the ...